MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Context Therapeutics (CNTX) Ownership - Who owns Context Therapeutics?
Profile
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
77.25M
P/E Ratio
N/A
Total Cash
84.8M
Projected Growth
N/A
Total Debt
244.36K
Revenue
N/A
Risk (Beta)
2.04
Dividend Yield
N/A
Total Cash/Share
1.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CNTX
Capitalization
77.2M
P/E Ratio
N/A
Risk (Beta)
2.04
Dividend Yield
N/A
Total Cash
84.8M
Total Cash/Share
1.13
Total Debt
244K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
83.9M
P/B Ratio
0.91
Cash Flow
N/A
Earnings
-0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
75K
Current Ratio
36.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-32.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-55.16
Shares Held By Institutions
127M
Shares Outstanding - Current
75M
Total Liabilities
2.47M
Total Volume MTD
N/A
Value
1
Gain YTD
-9.735
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com